Mrv0541 03071412362D 25 25 0 0 0 0 999 V2000 -1.6555 0.3818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3700 -0.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.0844 0.3818 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -3.8690 0.1268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3539 0.7942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8690 1.4616 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -3.0844 1.2067 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -2.3700 1.6192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6555 1.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.1239 -0.6577 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.1239 2.2462 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.9376 1.6212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9376 2.4502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2197 2.8646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4981 2.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2126 2.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9270 2.4499 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.2101 3.6894 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.9374 -0.0324 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.2197 0.3824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4984 -0.0317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2161 0.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9342 -0.0311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6519 0.3837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9372 -0.8649 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4 3 1 0 0 0 0 3 2 1 1 0 0 0 7 3 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 6 0 0 0 4 5 1 0 0 0 0 6 5 1 0 0 0 0 9 8 1 0 0 0 0 1 2 2 0 0 0 0 4 10 2 0 0 0 0 6 11 1 6 0 0 0 9 12 2 0 0 0 0 14 13 1 0 0 0 0 12 13 1 0 0 0 0 15 14 1 0 0 0 0 16 15 1 0 0 0 0 17 16 1 0 0 0 0 16 18 2 0 0 0 0 19 1 1 0 0 0 0 20 19 1 0 0 0 0 21 20 1 0 0 0 0 22 21 1 0 0 0 0 23 22 1 0 0 0 0 24 23 1 0 0 0 0 19 25 1 6 0 0 0 M END > CHEBI:15555 > prostaglandin D2 > A member of the class of prostaglandins D that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,9α,13E,15S- stereoisomer). > 3 > CHEBI:45044; CHEBI:10916; CHEBI:246; CHEBI:26321 > Prostaglandin D2; PGD2; PGD2; 11-Dehydroprostaglandin F2-alpha; (5Z,13E,15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate; (5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate; (5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate > (5Z,13E,15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid > C20H32O5; C20H32O5 > 352.46510 > 352.22497 > 0 > CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O > InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-18,21-22H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-/m0/s1 > BHMBVRSPMRCCGG-OUTUXVNYSA-N > 41598-07-6 > 2170623 > 41598-07-6 > DB02056 > C00696 > LMFA03010004 > PG2 > Prostaglandin_D2 > 15843042; 24298012; 24447364; 24456221 $$$$